Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus
Clinical trial NCT03231709 · COMPLETED
Trial details
- NCT number
- NCT03231709
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-18
- Primary completion
- 2018-02-09
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.